March 15, 2021

Doubting the doubter

Doubter71050722 tweets this morning that the CEO sold 750,000 shares after the Q4 results call, and everyone on Twitter doubts him.  Stock even shoots up nearly 30% pre-market.

But he provides a link to the emailed forms on the SEC website.

He also notes that the CFO also sold 40,000 shares.
 
Now, why are they in such a rush to sell, if the "FDA approval" (as the CEO likes to mislead and misbrand the supposedly-pending FDA clearance) were to come within "two weeks" of March 2,  that is, on March 16, tomorrow?



Update (March 17, 2021):  Director Onn Fenig follows the CEO and CFO lead and sells all his 12,573 shares.  But the CEO insists at the Oppenheimer conference today that "FDA approval" will be coming any day - he is an artist!

Update April 5, 2021:  Nanox got clearance for a Nanox.Cart (an ugly device).

No comments:

Post a Comment